- Interceded with the FDA when the agency failed to provide final approval for our client's product because it had granted orphan drug status for a similar product developed by another company. Our client's product was approved.
- Successfully assisted FDA and USDA on safety risk assessments for biotech processes, including managing industry reaction and press.
- Secured key witnesses to testify before an FDA advisory committee in support of a product that had originally been rejected; the product was later approved.
- Worked with Congress to encourage FDA to implement its own enforcement regulations by banning unapproved drugs, resulting in a clear path for our client to market their approved product.